Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 3

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 3
---
 Act of 1933, as amended (the “Securities Act”).

We will pay the expenses incurred in registering under the Securities Act the offer and sale of the shares of common stock to which this prospectus relates by the Selling Stockholder, including legal and accounting fees. See section titled “ Plan of Distribution” beginning on page 128 of this prospectus.

Shares of our common stock are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “JUNS”. On November 25, 2025, the closing price of our common stock was $1.18. The price of our common stock is volatile. From December 4, 2024, the day when the Company began trading on the Nasdaq through November 25, 2025, our common stock has traded at a low of $0.51 and a high of $19.51.

We are an “emerging growth company” under applicable federal securities laws and are subject to reduced public company reporting requirements.

Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described in the section titled “ Risk Factors” beginning on page 14 of this prospectus, and under similar headings in any amendments or supplements to this prospectus.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities, or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025.</div>

<div align='center'>TABLE OF CONTENTS</div>

| ABOUT THIS PROSPECTUS                                                                           |   1 |
| MARKET, INDUSTRY AND OTHER DATA                                                                 |   1 |
| TRADEMARKS AND COPYRIGHTS                                                                       |   1 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS                                            |   2 |
| PROSPECTUS SUMMARY                                                                              |   4 |
| THE OFFERING                                                                                    |  13 |
| RISK FACTORS                                                                                    |  14 |
| USE OF PROCEEDS                                                                                 |  59 |
| DETERMINATION OF OFFERING PRICE                                                                 |  59 |
| THE STANDBY EQUITY PURCHASE AGREEMENT                                                           |  59 |
| DIVIDEND POLICY                                                                                 |  66 |
| MARKET PRICE FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS                                  |  66 |
|